Patent · US Active

ROR gamma (RORγ) modulators

US10196350B2 · kind B2 · utility

2Cited by
0References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 1, 2017
Grant dateFeb 5, 2019
Priority date
Expiry dateDec 1, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to compounds according to (Formula IA) or (Formula IB): The compounds can be used as inhibitors of RORγ and are useful for the treatment of RORγ mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.